Fundraising Fox
🦊/Companies
Sign in

Tvaster Genkalp

2 known investors

Find your way into Tvaster Genkalp

Tvaster Genkalp is a Chennai-based molecular diagnostics startup that develops liquid biopsy tests using AI-driven epigenetics for non-invasive cancer detection, including its Episcreen Liver test for liver cancer.

Investors · 2

Ideaspring CapitalBengaluru · $2M
BIRACreportedNew Delhi

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Latest Funding News: Five Ventures Raise $92.25M and FoundHER Challengetice.news · Apr 2025Tvaster Genkalp secures $1.25 M funding to advance liquid biopsy cancer diagnosticsbiospectrumindia.com · Apr 2025Tvaster Genkalp Secures $1.25M to Advance Liver Cancer Detection with Episcreen™ - Indian Startup Timesindianstartuptimes.com · Apr 2025Tvaster Genkalp, Entvin AI, and Evenflow Secure Fresh Funding to Fuel Growthindia.entrepreneur.com · Apr 2025Tvaster Genkalp secures $1.25 million from Ideaspring Capital - The Economic Timeseconomictimes.indiatimes.com · Apr 2025Tvaster Genkalp - 2025 Funding Rounds & List of Investors - Tracxntranslate.google.com · Jun 2024

Frequently asked questions

What does Tvaster Genkalp do?
Tvaster Genkalp is a Chennai-based molecular diagnostics startup that develops liquid biopsy tests using AI-driven epigenetics for non-invasive cancer detection, including its Episcreen Liver test for liver cancer.
Who are Tvaster Genkalp's investors?
Tvaster Genkalp's investors include Ideaspring Capital, BIRAC.